Painful Intercourse — Symptoms, Causes & Treatment | MyMedicPlus

Dyspareunia is the medical term for recurrent or persistent genital pain associated with sexual intercourse — occurring before, during, or after penetration. It is classified anatomically and clinically into two distinct types: superficial dyspareunia (entry dyspareunia — pain localised to the vaginal vestibule, vulva, or introitus during initial penetration, often described as burning, stinging, or tearing at the vaginal entrance); and deep dyspareunia (pain felt in the pelvis, lower abdomen, or vaginal apex during deep thrusting, in certain sexual positions, or in the hours or days after intercourse). Dyspareunia affects approximately 10-20% of sexually active women across all age groups — with highest prevalence in postmenopausal women (40-60%, primarily due to genitourinary syndrome of menopause) and in premenopausal women with endometriosis or vulvodynia. It is one of the most significantly underreported gynaecological conditions — due to embarrassment, cultural barriers, assumption that pain during sex is normal or expected, or prior dismissal by healthcare providers; studies show that women wait an average of 3-4 years before seeking professional help for dyspareunia. Despite this, dyspareunia has highly identifiable and treatable causes in the majority of cases — accurate diagnosis and appropriate treatment (ranging from topical oestrogen and lubricants to pelvic floor physiotherapy, CBT, and surgical excision of endometriosis) lead to significant improvement in the vast majority of women. DSM-5 combines dyspareunia and vaginismus under the single diagnostic category of 'Genito-Pelvic Pain/Penetration Disorder' (GPPPD), reflecting their frequent co-occurrence and shared psychological components. Dyspareunia also occurs in men (penile pain during intercourse — from phimosis, Peyronie's disease, or prostatitis) but is far more commonly discussed and researched in women.

Causes of superficial (entry) dyspareunia: vulvodynia and vestibulodynia (localised vulvar pain syndrome — the most common cause of superficial dyspareunia in premenopausal women; characterised by provoked vestibular allodynia, burning, or stinging at the vaginal vestibule; positive Q-tip test — pain with minimal touch of the vestibule; the underlying mechanism involves neuroproliferation with C-fibre hypersensitisation and central sensitisation, not infection or structural disease); genitourinary syndrome of menopause (GSM — previously called vaginal atrophy or atrophic vaginitis; oestrogen deficiency from menopause, postpartum breastfeeding, or hormonal contraception causes thinning and loss of rugae in vaginal epithelium, reduced lubrication, loss of vaginal pH maintenance, and increased susceptibility to abrasion and microtears during intercourse — an exceedingly common and highly treatable cause); vulval skin conditions (lichen sclerosus — autoimmune parchment-like thinning and scarring that particularly affects the vulva, introitus, and perineum, causing tearing and agglutination; lichen planus — erosive variant causes painful raw mucosal surfaces); Bartholin gland cyst or abscess (causes focal swelling and pain at the posterolateral vaginal introitus); vaginismus (involuntary and reflexive contraction of the pelvic floor muscles and pubococcygeus — in response to anticipation or attempt of penetration — preventing or making penetration extremely painful; a predominantly psychosexual and musculoskeletal condition); and inadequate arousal or insufficient foreplay causing insufficient natural lubrication. Causes of deep dyspareunia: endometriosis (the most common and important cause of deep dyspareunia — present in 70-90% of women with deep dyspareunia; endometriotic implants on the uterosacral ligaments, rectovaginal septum, or ovaries cause deep aching pain with penetration or specific positions; severity of dyspareunia does not correlate with the stage of endometriosis — minimal-mild disease can cause severe pain); pelvic inflammatory disease (PID — chronic or acute tubo-ovarian infection causing adnexal tenderness and pelvic adhesions); uterine fibroids (particularly posterior or cervical fibroids); ovarian cysts (particularly endometriomata or ruptured cysts); pelvic floor hypertonicity (hypertonic pelvic floor from musculoskeletal dysfunction — often coexists with vulvodynia and vaginismus); post-surgical or post-radiation pelvic adhesions; and interstitial cystitis/bladder pain syndrome (causes deep pelvic pain with penetration).

Superficial dyspareunia symptoms: pain, burning, tearing, or stinging sensation at or immediately inside the vaginal opening (introitus and vestibule) — occurring at the moment of attempted penetration or during shallow penetration; may also occur with tampon insertion, gynaecological examinations, or even tight clothing pressure on the vulva; the character of pain ranges from mild discomfort to severe, sharp burning that immediately prevents any penetration. On clinical examination: vestibular erythema and allodynia (pain with minimal, non-invasive touch of the vestibular mucosa with a cotton swab — the Q-tip test is positive in vestibulodynia; pain score typically 5-9 out of 10 from a light touch that should not be painful) is pathognomonic of provoked vestibulodynia. In vaginismus: visible contraction and withdrawal of the pelvic floor, inability to complete a speculum examination without distress, and elevation of the perineum. In GSM: vaginal paleness and loss of rugae, reduced lubrication on stimulation, and post-coital spotting or light bleeding from fragile atrophic epithelium. Deep dyspareunia symptoms: aching, pressure, or sharp pain deep in the pelvis, vaginal apex, lower abdomen, or sacrum — occurring during deep penetration, or in specific sexual positions that involve deep thrusting (woman-on-top or rear-entry positions that maximise depth, typically worst for endometriosis); the pain may persist for hours or days after intercourse (post-coital ache is characteristic of endometriosis and pelvic congestion syndrome). Associated diagnostic clues by underlying cause: endometriosis — moderate to severe dysmenorrhoea (period pain), cyclical pelvic pain worsening during menstruation, subfertility; pelvic inflammatory disease (PID) — vaginal discharge (mucopurulent), fever, cervical motion tenderness on examination; genitourinary syndrome of menopause — vaginal dryness, urinary urgency and frequency, recurrent UTIs, post-coital spotting in a postmenopausal woman; lichen sclerosus — vulval itching (severe and persistent), pallor, skin fusion or agglutination of labia minora to majora.

Thorough clinical history is the essential first step — establishing: the exact location, character, and severity of pain; superficial vs. deep; timing in relation to the menstrual cycle (cyclical pain worsening with menstruation strongly suggests endometriosis); duration and onset (acute vs. chronic; onset in relation to menopause, contraceptive change, childbirth, surgery, or sexual trauma); associated symptoms (dysmenorrhoea, intermenstrual bleeding, vaginal discharge, urinary symptoms, subfertility); and the patient's sexual history, prior STIs, contraception, and any prior investigations or treatments. Vulval and speculum examination is the cornerstone of physical diagnosis — performed under adequate lighting with magnification when possible; it allows assessment of vulval skin (pallor, fissuring, and skin loss in lichen sclerosus; erosive lesions in lichen planus; erythema in vulvodynia); vaginal mucosa (atrophic changes from oestrogen deficiency in GSM; discharge suggesting infection); and cervical appearance (friable, inflamed in cervicitis; contact bleeding). The Q-tip test (cotton swab test): the examiner applies minimal pressure with a moistened cotton swab to specific clock-face positions around the vestibule (12, 3, 6, and 9 o'clock) — a positive test (pain score 5 or above from light touch alone) confirms vestibulodynia/provoked vestibular allodynia and localises the distribution of hyperalgesia. STI screening: endocervical or high vaginal swabs for Chlamydia trachomatis and Neisseria gonorrhoeae (nucleic acid amplification testing — NAAT), herpes simplex virus (HSV) swab if vesicles or ulceration present, and Trichomonas vaginalis — essential in all women with deep pelvic pain or discharge to exclude PID. Transvaginal ultrasound (TVUS): the primary imaging investigation for structural causes of deep dyspareunia — identifies endometriomata (chocolate cysts — round, homogeneous, low-level echogenicity ovarian cysts), uterine fibroids, ovarian cysts, hydrosalpinx from prior PID, and free pelvic fluid. Diagnostic laparoscopy: the gold standard for confirming or excluding endometriosis — TVUS misses peritoneal and deep infiltrating endometriosis; laparoscopy allows direct visualisation, biopsy, and concurrent surgical treatment. Pelvic floor assessment: physiotherapy assessment of pelvic floor muscle tone, tenderness, and function is essential in suspected vaginismus or hypertonic pelvic floor dysfunction — internal palpation of levator ani, obturator internus, and pubococcygeus identifies specific muscle tenderness and trigger points.

Genitourinary syndrome of menopause (GSM): topical vaginal estrogen (pessary, cream, or ring) is highly effective and has minimal systemic absorption. Non-hormonal options: vaginal lubricants (water-based for intercourse), vaginal moisturizers (regular use for daily dryness). Vestibulodynia: pelvic floor physiotherapy (reduces hypertonia and vestibular sensitivity), topical lidocaine, low-oxalate diet (limited evidence), vestibulectomy for localized intractable cases. Vaginismus: progressive vaginal dilator therapy, CBT, pelvic floor physiotherapy. Endometriosis-related dyspareunia: hormonal suppression (OCP, GnRH agonists, progestins), laparoscopic excision. Regular monitoring of treatment response, early detection of side effects, and ongoing assessment of disease progression are essential components of optimising patient outcomes over the long term. Treatment plans should be proactively reviewed and appropriately adjusted based on clinical response, patient-reported tolerability, changing patient circumstances, and continuously evolving evidence-based clinical guidelines. Meaningful shared decision-making between patients and their healthcare team, incorporating patient values and treatment preferences, consistently improves both treatment adherence and long-term outcomes.

Untreated dyspareunia causes avoidance of sexual activity, relationship strain, and secondary sexual dysfunction (reduced desire, arousal difficulty). The pain-avoidance-pain cycle reinforces vaginismus. Psychological consequences include anxiety, depression, reduced self-esteem, and relationship distress. Endometriosis causing deep dyspareunia is associated with infertility if untreated. Fear of pain anticipation (pain catastrophizing) perpetuates and amplifies the experience of dyspareunia. Long-term specialist follow-up and structured regular review are essential to detect and appropriately manage complications at the earliest possible stage, minimising long-term disability, preserving organ function, and improving the overall prognosis. Patient education about the early warning signs of complications and clear guidance on when to seek urgent medical attention empowers timely help-seeking behaviour and reduces preventable serious adverse outcomes. Psychological impact — including depression, anxiety, and reduced quality of life — should be proactively assessed and addressed as part of comprehensive complication management.

Ensure adequate sexual arousal before penetration: the vagina naturally lubricates only after sufficient psychological and physical arousal — inadequate foreplay is a common and entirely preventable cause of superficial dyspareunia from friction on unlubricated mucosa; dedicating more time to non-penetrative sexual activity and using a water-based vaginal lubricant (avoid oil-based with latex condoms) during intercourse eliminates this category of dyspareunia entirely. Early initiation of topical vaginal oestrogen for genitourinary syndrome of menopause: starting at the menopause transition (or as early as perimenopause if dryness symptoms are present) with low-dose local vaginal oestrogen (estradiol pessary 10-25 mcg, vaginal cream, or oestradiol-releasing ring) prevents the progressive vaginal atrophy that ultimately causes dyspareunia; topical vaginal oestrogen at standard doses has negligible systemic absorption and is safe even in most breast cancer survivors in consultation with an oncologist; women who delay treatment allow atrophic changes to progress to a severity that is harder to reverse. Pelvic floor physiotherapy referral before and after gynaecological surgery (hysterectomy, anterior repair, pelvic organ prolapse surgery) and pelvic radiation (for cervical, uterine, or rectal cancer) prevents and treats the post-surgical pelvic floor dysfunction, adhesions, and vaginal stenosis that cause post-treatment dyspareunia — this is a standard of care in specialist gynaecological oncology but should be more widely implemented. Early diagnosis and treatment of endometriosis: the average diagnostic delay for endometriosis in the UK is 7-10 years; earlier diagnostic laparoscopy in young women with significant dysmenorrhoea and progressive deep dyspareunia reduces the extent of endometriosis progression and adhesion formation. Desensitisation and psychological support: progressive graded vaginal dilator therapy combined with CBT and sex therapy, initiated as soon as vaginismus or avoidance behaviour is identified, prevents the progressive worsening of the pain-avoidance-fear cycle. Open, non-judgmental clinical communication from healthcare providers is essential — many women require encouragement that painful intercourse is worth reporting and is not inevitable.

See a GP or gynaecologist for: pain during intercourse (dyspareunia) that is persistent, worsening, or significantly affecting quality of life or relationships — do not accept this as normal; pain occurring specifically on deep penetration (deep dyspareunia — suggests uterine or pelvic cause such as endometriosis, pelvic inflammatory disease, or uterine fibroids); pain at the vaginal opening with any penetration attempt — particularly if associated with muscle tightening (vaginismus — highly treatable with pelvic floor physiotherapy and sex therapy); significant vaginal dryness and pain during intercourse in a post-menopausal or breastfeeding woman — effective treatment (vaginal oestrogen) is available and safe. Seek urgent assessment for: new severe pelvic pain associated with fever and vaginal discharge (possible pelvic inflammatory disease — requires antibiotics); or pain with one-sided pelvic tenderness and a positive pregnancy test (possible ectopic pregnancy — an emergency). Never feel embarrassed to raise this symptom with a doctor — dyspareunia has multiple treatable causes, and a pelvic examination, vaginal swabs, and sometimes pelvic ultrasound can usually identify the underlying cause.